News

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026Announced positive data from Phase 1b/2a RESOLVE supporting ...
Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) andBLA submission anticipated in 1H ...
After teasers, vivo India launched its latest vivo V-series smartphone - vivo V60, the successor to last year's vivo V50, ...
Matrix Asset Advisors, an asset management company, released its Q2 2025 investor letter. A copy of the letter can be ...
At an event in New Delhi, Vivo today launched its photographic focussed vivo V60 smartphone. The vivo V60 comes with a flagship quad-camera system ...
The most widely discussed rumor is that Apple might be introducing its slimmest phone ever, the iPhone Air, which may replace ...
As momentum builds toward the highly anticipated GDAI 2025, DataGlobal Hub is proud to unveil what participants should expect ...
Background Women with pre-eclampsia are at increased risk of later-life cardiovascular disease (CVD). Despite suggestions that women affected by pre-eclampsia should undergo routine CVD screening, ...
Beautifully made and designed, the only thing holding back the EVO-T1 is a processor meant for laptops. But if you want the ...
Not only does it look delightful, but it can also handle itself rather well when taken off the beaten path and onto rugged ...